Attention deficit hyperactivity disorder (ADHD) is a common disorder of childhood characterized by inattention, excessive motor activity, impulsivity, and distractibility. It is associated with serious disability in children, adolescents and adults. 1 The etiology of the disorder is unknown, but it has a strong genetic component. Pharmacological and biochemical studies have suggested that dopaminergic and noradrenergic systems are involved.
ADHD affects between 4% and 6% of the school-age population. 4, 5 It affects boys two to three times more frequently than girls and leads to significant behavioral problems, impaired family and social relationships and major difficulties in school. Many children with ADHD develop conduct disorder and the long-term outcome is poor.
1 ADHD is familial 6 and twin studies estimate heritability (h 2 ) at 80-90%. [7] [8] [9] The mode of transmission is unknown, but is likely to be due to many genes, each of small effect. Overall 1st.Deg.Rel is [5] [6] 10 suggesting that relative risks at individual loci will be small, and below the resolution of linkage studies. 11 We 3 previously confirmed an association 12 with the 480-bp allele of a VNTR situated in the 3Ј untranslated region of the DAT1 gene. 13 A further replication of this finding is provided by Waldman et al. 14 However, recent work proposes a more complicated neurochemical process including relative hypo-and hyper-dopaminergic function and involving the noradrenergic system. 2 We therefore extended our studies to include other monoamine-related genes.
The dopamine transporter gene is a member of a family of Na + and Cl − dependent neurotransmitter transporters containing twelve transmembrane domains. 15 This gene confers all of the pharmacological properties of the rat dopamine re-uptake carrier 16 including the capacity to bind cocaine and other psychostimulant drugs. A 40-bp polymorphic tandem repeat was identified in the 3Ј UTR and was used in the present study. Dopamine-␤-hydroxylase (D␤H) catalyses the conversion of dopamine to noradrenaline. The gene (DBH) is closely linked to the ABO blood group on chromosome 9q34. Enzyme activity in serum or plasma is a stable, highly heritable, biochemical phenotype, 17 and as the major genetic determinant of serum D␤H is also linked to ABO, it suggests that DBH is a QTL for D␤H activity. We have used a TaqI polymorphism in the 5th intron in the present study. The dopamine D5 receptor has a similar genomic structure to DRD1, having a single small exon within the 5Ј untranslated region. DRD5 and DRD1 share many functional properties since they both stimulate adenylate cyclase activity, although DRD5 binds dopamine with a 10-fold greater affinity than D1. 18 We have used a CA repeat isolated from a cosmid clone which contains the DRD5 gene. 19 To avoid possible population stratification in the sampling of cases and controls we used the haplotypebased haplotype relative risk method in a sample of 118 children and 200 of their parents. We chose this as our primary method of analysis although we also tested for transmission disequilbrium using the Transmission Disequilibrium Test. 20 The 480-bp DAT1 allele, the TaqI (present) DBH allele (A2) and the 148-bp DRD5 allele were each preferentially transmitted to affected children (see Table 1 ). For DAT1 the 480-bp allele is transmitted (t) 145 times and not transmitted (nt) 121 times. The equivalent data for the DBH A2 is 124 t, 95 nt and for DRD5 148 bp, 90 t, 54 nt. These three genes were part of our ongoing study of seven polymorphisms at dopamine system related genes. The preferential transmissions remain statistically significant at the Ͻ0.05 level after correction for multiple tests.
We previously published data for DAT1 on a subset of the present samples. 3 The additional sample is independently significant for transmission of the 480-bp DAT1 allele (one-tailed P = 0.039). Thus, preferential transmission of the 480-bp DAT1 allele has been found in two separate samples derived from the same population. The data in Table 1 are for the combined sample. DAT1 is a prime candidate gene because of the well known, and paradoxical, therapeutic effect of stimulant drugs such as methylphenidate. Although these agents affect all monoamines to some extent, recent hypotheses have focused on dopamine neurotransmission (DA), in part due to imaging studies T  145  42  187  63  19  82  82  23  105  NT  121  66  187  49  33  82  72  33  105  Total  266  108  374  112  52  164  154  56 Total  A148  AO  Total  A148  AO  Total   T  90  70  160  35  35  70  55  35  90  NT  54  106  160  22  48  70  32  58  90  Total  144  176  320  57  83  140  87  93 We have not found preferential transmission of marker alleles at DRD4, DRD2, or TH in our sample (Gill et al, in preparation) . DRD2 and TH have not been examined in other samples, but our negative DRD4 data conflict with the findings of LaHoste et al, 23 Swanson et al, 24 and Smalley et al, 25 but concur with Rowe et al 26 and Castellanos et al. 27 These differences may be due to genetic heterogeneity, with different genes conferring risk for ADHD in the Irish population. Clinical heterogeneity may also contribute to differences in findings with samples potentially differing in severity, clinical subtype, or the presence of co-morbid conditions.
For DAT1 and DBH, transmission of the 'associated' alleles was stronger for families with at least one parent who was retrospectively diagnosed as ADHD using a score on the Wender Ͼ36. 28 For DAT1, the RR in familial cases is 1.29 (1.01-1.59) compared to a RR in nonfamilial cases of 1.20 (0.97-1.34). It is interesting to note that the previously published sample 3 had a greater concentration of familial cases than in the additional sample, which was of marginal significance with respect to transmission of the 480-bp DAT1 allele (one-tailed P = 0.039). The RR for DBH for familial cases was 1.49 (1.10-2.00) compared to 1.20 (0.96-1.49) for non-familial cases, similar to the data for DAT1. The differences in RR between FH+ve and FH−ve samples are not, however, statistically significant for either marker. Examining transmission from 19 parents retrospectively diagnosed as ADHD and heterozygous for the 480-bp DAT1 allele, transmission occurred 15 times. For those ADHD parents heterozygous for DBH, the 'associated' allele was transmitted 15 times and not transmitted only twice. These data suggest that variation at DAT1 and DBH confers risk particularly for a familial subtype of ADHD. For DRD5, this relationship with family history does not hold and if anything, transmission is stronger in non-familial cases. This is in contrast to the DAT1 and DBH results and could suggest that DRD5 variation confers differential risk for a more general 'activity' or 'attention' trait within the population. TDT analysis for the combined subtypes of the disorder, in complete trios only, demonstrates that for each gene, there is linkage in the presence of linkage disequilibrium, with P Ͻ 0.05, for DAT1 P Ͻ 0.005 for DBH and P Ͻ 0.01 for DRD5. This analysis is not independent of the HHRR analysis and indeed, should be highly correlated. In the study by Waldman et al, 14 the strongest effect was found for the combined subtype of the disorder, a finding reflected in our data. Odds ratios, relative risks and attributable fractions (AF) for each of the three genes are given in Table 2 . AF is calculated using the formula based on the frequency of the risk factor (the 'associated' allele) in the population, in our case the frequency of the nottransmitted 'associated' allele in the parents.
29 DRD5 has the strongest contribution (0.20) with DBH at 0.12 and DAT1 0.08.
The findings at the DBH and DRD5 loci require independent replication before being accepted. In addition, there remains the possibility that real or apparent meiotic segregation distortion might exist at these loci. Assuming replication occurs in independent samples, then examination of further polymorphic markers across each locus should allow a more precise localization of the DNA variation conferring risk. The functional significance, if any, of the associated alleles will assist with the construction of plausible hypotheses with regard to the biological basis of ADHD.
Methods
Patients were recruited from child psychiatric clinics and schools in west County Dublin and from the Hyperactive and Attention Deficit Children's Support Group of Ireland. A consensus diagnosis of DSM-IV ADHD or UADD either with or without comorbidity, based on all available clinical data and the rating scales as described below was reached between GD, a psychologist and MF, a consultant child psychiatrist. The rating scales were: (1) The Child Behavior Checklist (CBCL), a widely used behavioral symptom measure 30 and the records of child behavior problems and social competencies as reported by parents; (2) The Connors Parent and Teacher Rating Scales, 31 48-item parent and 39-item teacher rating scales, in wide use in child psychiatry; (3) The Comprehensive Teacher's Rating Scale (ACTeRS), 32 which includes 24 items relevant to classroom behavior. The items fall into four factors: Attention, Hyperactivity, Social Skills and Oppositional behavior. These factors have high internal consistency, test-retest reliability, factor-pure items and good interrater agreement; (4) The 25-item Wender-Utah Rating Scale (WURS) 28 was applied to all parents. A cutoff score of 36 or higher is 96% sensitive and 96% specific for adults with ADHD as children.
One hundred and eighteen children were assessed from 111 families. Twenty-four families consisted of mother and affected child, one family consisted of father and affected child, and 93 families consisted of mother, father and affected child (trios). One hundred and six (90%) of probands had ADHD combined type, nine (7.6%) the inattentive type, three (2.5%) the hyperactive/impulse subtype and two (1.7%), Undifferentiated Attention Deficit Disorder (UADD). The age range of the sample was between 4 and 14 years, with males accounting for 86%. The families were ethnically Irish with the exception of two families (in one, the father was Arabian, and in the other the father was Croatian). Approximately 80% of the children in this study with ADHD also met diagnostic criteria for other disorders, with oppositional defiant disorder and conduct disorder occurring in approximately 90% of cases. Eighteen per cent had co-morbid mood disorders, 22% anxiety disorders and 20% specific learning disabilities. Familiality was defined as the presence of one or more parents with a score on the Wender 28 of Ͼ36. DNA was extracted from buccal cells. Two cytology brushes were cut into an eppendorf tube, 500 l of 50 mM NaOH was added, vortexed for 60 s and incubated at 95°C for 10 min in a heat block. Fifty l of 1 M Tris (pH 8.0) was added to each. Tubes were vortexed for a further 30 s and 200 l of Biorad matrix (Instagene) added followed by a second incubation at 56°C, for a period of 30 min. The samples were then vortexed for 10 s, incubated at 100°C for 8 min in a heat block and given a final vortex for 10 s. The brushes were removed, the samples were centrifuged at 12 000 rpm for 3 min, and the supernatant transferred to a fresh eppendorf tube which was stored at −20°C until repurification using proteinase K/SDS, followed by phenol/chloroform extraction and precipitation of the DNA with ethanol.
PR amplification of the region flanking the DAT1 40-bp VNTR was achieved (as described by Cook et al 12 using the following pair of primers: sense (5Ј TGT GGT GTA GGG AAC GGC CTG AG 3Ј, antisense (5Ј CTT CCT GGA GGT CAC GGC TCA AGG 3Ј). Forty-five cycles of amplification were performed at 96°C for 30 s, 68°C for 30 s and 72°C for 90 s. Ten l of product were loaded on a 6% polyacrylamide gel and electrophoresed at 140 V for 3-4 h. Three different alleles were identified; 520 bp (allele 1); 480 bp (allele 2) and 440 bp (allele 3). A 464-bp PCR fragment of intron 5 of the DBH gene was amplified with the primers as follows: forward (5Ј CTG TAT TTG GAA CTT GGC ATC 3Ј) and reverse (5Ј AGG CAT TTT ACT ACC CAG AGG 3Ј). Thirty cycles of denaturing were at 94°C for 1 min, annealing at 59°C for 1 min and extension at 72°C for 1.5 min. A first denaturing step of 95°C for 3.5 min and a final extension step of 72°C for 5 min were added. The PCR product was digested with Taq I, and fragments separated in 2% agarose. Taq I identifies a twoallele polymorphism with an undigested band of 464 bp (allele 1) and two bands of 300 bp and 164 bp (allele 2). Amplification of the DRD5 (CT) n repeat was achieved as described 18 using the following pair of primers: forward (5Ј CGT GTA TGA TCC CTG CAG 3Ј) and reverse (5Ј GCT CAT GAG AAG AAT GGA GTG 3Ј). ␣32p-dCTP was incorporated in the PCR mix. Each reaction contained 1 pM of each primer and used an annealing temperature of 60°C. Alleles were separated on a 6% polyacrylamide gel. This repeat had 12 alleles: 156 bp; 154 bp; 152 bp; 150 bp; 148 bp; 146 bp; 144 bp; 142 bp; 140 bp; 138 bp; 136 bp; 134 bp.
A non-matched analysis for transmitted and nontransmitted parental alleles was employed. Terwilliger and Ott 33 refer to it as the haplotype-based haplotype relative risk (HHRR). TDT was performed by counting the number of transmissions of the associated allele from heterozygous parents only for complete trios. 20, 34 Attributable fraction (AF) was calculated according to the formula AF = f(RR − 1)/1 + f(RR − 1), 29 where RR = relative risk and f = frequency of the 'associated' allele among parental non-transmitted alleles. RR is calculated from the four cells in the HHRR table according  to 
